Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 34026 - 34050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Calcitriol	Approved Investigational Nutraceutical	OLFML1	283298	downregulated	Calcitriol results in decreased expression of OLFML1 mRNA	11p15.4	A22299
Calcitriol	Approved Investigational Nutraceutical	OLFML2B	25903	downregulated	Calcitriol results in decreased expression of OLFML2B mRNA	1q23.3	A22299
Calcitriol	Approved Investigational Nutraceutical	OLFML3	56944	downregulated	Calcitriol results in decreased expression of OLFML3 mRNA	1p13.2	A22299
Calcitriol	Approved Investigational Nutraceutical	OLR1	4973	downregulated	Calcitriol results in decreased expression of OLR1 mRNA	12p13.2	A22300
Calcitriol	Approved Investigational Nutraceutical	OMG	4974	upregulated	Calcitriol results in increased expression of OMG mRNA	17q11.2	A22303
Calcitriol	Approved Investigational Nutraceutical	OPHN1	4983	upregulated	Calcitriol results in increased expression of OPHN1 mRNA	Xq12	A22301
Calcitriol	Approved Investigational Nutraceutical	OPTN	10133	upregulated	Calcitriol results in increased expression of OPTN mRNA	10p13	A22301
Calcitriol	Approved Investigational Nutraceutical	ORC1	4998	downregulated	Calcitriol results in decreased expression of ORC1 mRNA	1p32.3	A22301
Calcitriol	Approved Investigational Nutraceutical	ORC4	5000	upregulated	Calcitriol results in increased expression of ORC4 mRNA	2q23.1	A22300
Calcitriol	Approved Investigational Nutraceutical	ORC6	23594	downregulated	Calcitriol results in decreased expression of ORC6 mRNA	16q11.2	A22301
Calcitriol	Approved Investigational Nutraceutical	ORM1	5004	upregulated	Calcitriol results in increased expression of ORM1 mRNA	9q32	A22301
Calcitriol	Approved Investigational Nutraceutical	ORM2	5005	upregulated	Calcitriol results in increased expression of ORM2 mRNA	9q32	A22301
Calcitriol	Approved Investigational Nutraceutical	OSBPL1A	114876	upregulated	Calcitriol results in increased expression of OSBPL1A mRNA	18q11.2	A22301
Calcitriol	Approved Investigational Nutraceutical	OSBPL7	114881	upregulated	Calcitriol results in increased expression of OSBPL7 mRNA	17q21	A22301
Calcitriol	Approved Investigational Nutraceutical	OSGIN1	29948	upregulated	Calcitriol results in increased expression of OSGIN1 mRNA	16q23.3	A22301
Calcitriol	Approved Investigational Nutraceutical	OSR2	116039	upregulated	Calcitriol results in increased expression of OSR2 mRNA	8q22.2	A22300 A22301
Calcitriol	Approved Investigational Nutraceutical	OTUD7B	56957	upregulated	Calcitriol results in increased expression of OTUD7B mRNA	1q21.2	A22301
Calcitriol	Approved Investigational Nutraceutical	OTULIN	90268	upregulated	Calcitriol results in increased expression of OTULIN mRNA	5p15.2	A22300
Calcitriol	Approved Investigational Nutraceutical	OXTR	5021	downregulated	Calcitriol results in decreased expression of OXTR mRNA	3p25.3	A22299
Calcitriol	Approved Investigational Nutraceutical	OXTR	5021	upregulated	Calcitriol results in increased expression of OXTR mRNA	3p25.3	A22300
Calcitriol	Approved Investigational Nutraceutical	P2RY10	27334	downregulated	Calcitriol results in decreased expression of P2RY10 mRNA	Xq21.1	A22300
Calcitriol	Approved Investigational Nutraceutical	P2RY2	5029	upregulated	Calcitriol results in increased expression of P2RY2 mRNA	11q13.4	A22303 A22300
Calcitriol	Approved Investigational Nutraceutical	P4HA3	283208	downregulated	Calcitriol results in decreased expression of P4HA3 mRNA	11q13.4	A22299
Calcitriol	Approved Investigational Nutraceutical	PACS1	55690	upregulated	Calcitriol results in increased expression of PACS1 mRNA	11q13.1-q13.2	A22301
Calcitriol	Approved Investigational Nutraceutical	PACSIN1	29993	upregulated	Calcitriol results in increased expression of PACSIN1 mRNA	6p21.3	A22301

Displaying entries 34026 - 34050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability